CDT Equity Inc.
CDTTW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $221.8K in total; no superinvestor holds it.
Other share classesCDT
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 1
- 13F holdersQ2 2026, 0 vs. previous quarter
- 14
- 13F valueReported value at the end of Q2 2026
- $221.8K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CDTTW, Q2 2026
No superinvestor reported holding CDTTW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by CDT Equity Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)6:12 PM ET | Aug 28 | 5 daysLate | Regan AndrewChief Executive Officer | SSale | −290 | – | – | 0.0%5.69M after | |
| Jun 23, 2026 (view filing)6:40 PM ET | Jun 18 | 5 days | Taylor Mark Andrew and 2 others10% Owner | SSale | −2.07M | $1.42 | −$2.95M | −100.0%0 after | 4 lots |
| Oct 7, 2024 (view filing)7:38 PM ET | Oct 3-7 | 4 days | Stockton Ltd and 3 others10% Owner | SSaleCommon Stock, par value $0.0001 per share | −3.81M | $0.1033 | −$393.4K | −38.5%6.09M after | 3 lots |
| Oct 2, 2024 (view filing)5:02 PM ET | Sep 30-Oct 2 | 2 days | Stockton Ltd and 3 others10% Owner | SSaleCommon Stock, par value $0.0001 per share | −2.60M | $0.1145 | −$297.6K | −20.8%9.90M after | 3 lots |
| Sep 19, 2024 (view filing)5:01 PM ET | Jul 3-17 | 78 daysLate | Regan Andrew and 2 othersDirector, 10% Owner | SSale | −15.3M | $0.3001 | −$4.59M | −98.9%177.6K after | 10 lots |
| Apr 24, 2024 (view filing) | Apr 22 | 2 days | Farley Chele ChiavacciDirector | PPurchase | +200.3K | – | – | –203.3K after | Derivative |
| Apr 24, 2024 (view filing) | Apr 22 | 2 days | Tapolczay DavidChief Executive Officer | SSale | −200.3K | – | – | –200.3K after | Derivative |
Top 10 13F holders, Q2 2026
The largest institutional positions in CDT Equity Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boothbay Fund Management, LLC | 250,000 | $140.0K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 950,000 | $13.9K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 765,000 | $12.5K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 755,191 | $12.1K | 0.00% | −2000.0% | Reduced |
| MMCAP International Inc. SPC | 700,000 | $11.5K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 534,162 | $8.76K | 0.00% | −2000.0% | Reduced |
| Decagon Asset Management LLP | 400,000 | $6.56K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 375,000 | $4.13K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 243,532 | $3.99K | 0.00% | 00.0% | Unchanged |
| Rivernorth Capital Management, LLC | 200,000 | $2.36K | 0.00% | 00.0% | Unchanged |